1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC46A1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO RGD:1309472 6480464 1-Naphthylisothiocyanate results in decreased expression of SLC46A1 mRNA CTD PMID:25380136 17beta-estradiol increases expression ISO RGD:1606750 6480464 Estradiol results in increased expression of SLC46A1 mRNA CTD PMID:23019147 17beta-estradiol multiple interactions ISO RGD:1309472 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC46A1 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1309472 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC46A1 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SLC46A1 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC46A1 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1606750 6480464 Tetrachlorodibenzodioxin affects the expression of SLC46A1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC46A1 mRNA CTD PMID:21570461 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1309472 6480464 tetrabromobisphenol A results in decreased expression of SLC46A1 mRNA CTD PMID:27914987 3-Iodothyronamine affects uptake ISO RGD:1606750 6480464 SLC46A1 mRNA affects the uptake of 3-iodothyronamine CTD PMID:19074582 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1309472 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of SLC46A1 mRNA CTD PMID:25380136 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions ISO RGD:1606750 6480464 4 more ... CTD PMID:17475902 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid decreases activity ISO RGD:1606750 6480464 4 more ... CTD PMID:17475902 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SLC46A1 exon CTD PMID:33297965 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1606750 6480464 [Decitabine affects the methylation of SLC46A1 promoter] which affects the expression of SLC46A1 mRNA CTD PMID:18817749 5-formyltetrahydrofolic acid decreases activity ISO RGD:1606750 6480464 Leucovorin results in decreased activity of SLC46A1 protein CTD PMID:17475902 5-formyltetrahydrofolic acid multiple interactions ISO RGD:1606750 6480464 Leucovorin inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid] CTD PMID:17475902 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO RGD:1309472 6480464 Omeprazole affects the expression of SLC46A1 mRNA CTD PMID:19483382 5-methyltetrahydrofolic acid multiple interactions ISO RGD:1606750 6480464 5-methyltetrahydrofolate inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid] CTD PMID:17475902 5-methyltetrahydrofolic acid decreases activity ISO RGD:1606750 6480464 5-methyltetrahydrofolate results in decreased activity of SLC46A1 protein CTD PMID:17475902 6-propyl-2-thiouracil affects expression ISO RGD:1309472 6480464 Propylthiouracil affects the expression of SLC46A1 mRNA CTD PMID:19483382 acetamide decreases expression ISO RGD:1309472 6480464 acetamide results in decreased expression of SLC46A1 mRNA CTD PMID:31881176 AM-251 increases expression ISO RGD:1606750 6480464 AM 251 results in increased expression of SLC46A1 mRNA CTD PMID:19145103 amiodarone affects expression ISO RGD:1309472 6480464 Amiodarone affects the expression of SLC46A1 mRNA CTD PMID:19483382 antirheumatic drug decreases expression ISO RGD:1606750 6480464 Antirheumatic Agents results in decreased expression of SLC46A1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1606750 6480464 aristolochic acid I results in increased expression of SLC46A1 mRNA CTD PMID:33212167 ATP multiple interactions ISO RGD:1606750 6480464 [SLC46A1 protein results in increased susceptibility to N-((5-((2-amino-4-oxo-4 more ... CTD PMID:21879757 benzbromarone affects expression ISO RGD:1309472 6480464 Benzbromarone affects the expression of SLC46A1 mRNA CTD PMID:19483382 benzo[a]pyrene affects methylation ISO RGD:1606750 6480464 Benzo(a)pyrene affects the methylation of SLC46A1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1606750 6480464 Benzo(a)pyrene results in decreased expression of SLC46A1 mRNA CTD PMID:32234424 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of SLC46A1 mRNA CTD PMID:26377693 bisphenol A multiple interactions ISO RGD:1309472 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC46A1 mRNA, [bisphenol A co-treated with Testosterone] results in increased expression of SLC46A1 mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:1309472 6480464 bisphenol A results in decreased expression of SLC46A1 mRNA CTD PMID:25181051 more ... bromosulfophthalein multiple interactions ISO RGD:1606750 6480464 Sulfobromophthalein inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid] CTD PMID:17475902 bromosulfophthalein multiple interactions ISO RGD:1309472 6480464 Sulfobromophthalein inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid] CTD PMID:18174275 bromosulfophthalein decreases activity ISO RGD:1606750 6480464 Sulfobromophthalein results in decreased activity of SLC46A1 protein CTD PMID:17475902 cadmium atom increases expression ISO RGD:1606750 6480464 Cadmium results in increased expression of SLC46A1 mRNA CTD PMID:17156779 cadmium atom multiple interactions ISO RGD:1606750 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A1 mRNA CTD PMID:32645461 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A1 mRNA CTD PMID:32645461 cadmium dichloride increases expression ISO RGD:1606750 6480464 Cadmium Chloride results in increased expression of SLC46A1 mRNA CTD PMID:17156779 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of SLC46A1 mRNA, Cadmium Chloride results in decreased expression of SLC46A1 protein CTD PMID:27417525 cadmium dichloride multiple interactions ISO RGD:1606750 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A1 mRNA CTD PMID:32645461 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A1 mRNA CTD PMID:32645461 calciol increases expression ISO RGD:1606750 6480464 Cholecalciferol results in increased expression of SLC46A1 mRNA CTD PMID:22474172 calciol multiple interactions EXP 6480464 Cholecalciferol inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC46A1 mRNA] CTD PMID:25673501 calcitriol increases expression ISO RGD:1606750 6480464 Calcitriol results in increased expression of SLC46A1 mRNA CTD PMID:16002434 more ... carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 chromium(6+) decreases expression EXP 6480464 chromium hexavalent ion results in decreased expression of SLC46A1 mRNA CTD PMID:24418189 chromium(6+) decreases expression ISO RGD:1309472 6480464 chromium hexavalent ion results in decreased expression of SLC46A1 mRNA CTD PMID:24418189 cisplatin increases expression ISO RGD:1606750 6480464 Cisplatin results in increased expression of SLC46A1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1606750 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC46A1 mRNA CTD PMID:27392435 clofibrate affects expression ISO RGD:1309472 6480464 Clofibrate affects the expression of SLC46A1 mRNA CTD PMID:19483382 copper(II) sulfate decreases expression ISO RGD:1606750 6480464 Copper Sulfate results in decreased expression of SLC46A1 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1606750 6480464 Cyclosporine results in decreased expression of SLC46A1 mRNA CTD PMID:20106945 , PMID:25562108 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC46A1 mRNA CTD PMID:29950665 dorsomorphin multiple interactions ISO RGD:1606750 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1606750 6480464 Doxorubicin results in decreased expression of SLC46A1 mRNA CTD PMID:29803840 ethyl methanesulfonate increases expression ISO RGD:1606750 6480464 Ethyl Methanesulfonate results in increased expression of SLC46A1 mRNA CTD PMID:23649840 fenthion increases expression EXP 6480464 Fenthion results in increased expression of SLC46A1 mRNA CTD PMID:34813904 ferroheme b multiple interactions ISO RGD:1606750 6480464 SLC46A1 protein promotes the reaction [Heme results in increased expression of HMOX1 mRNA] CTD PMID:17156779 ferroheme b increases uptake ISO RGD:1606750 6480464 SLC46A1 protein results in increased uptake of Heme CTD PMID:17156779 folic acid multiple interactions ISO RGD:1606750 6480464 4 more ... CTD PMID:17475902 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC46A1 mRNA CTD PMID:22206623 folic acid increases transport ISO RGD:1606750 6480464 SLC46A1 protein results in increased transport of Folic Acid CTD PMID:17129779 more ... folic acid multiple interactions ISO RGD:1309472 6480464 [Folic Acid affects the susceptibility to Fructose] which affects the expression of SLC46A1 mRNA more ... CTD PMID:18174275 , PMID:31612177 folic acid increases transport ISO RGD:1309472 6480464 SLC46A1 protein results in increased transport of Folic Acid CTD PMID:18174275 folic acid increases uptake EXP 6480464 SLC46A1 protein results in increased uptake of Folic Acid CTD PMID:21346251 folic acid decreases expression ISO RGD:1606750 6480464 Folic Acid deficiency results in decreased expression of SLC46A1 mRNA, Folic Acid results in decreased expression of SLC46A1 mRNA CTD PMID:17616776 , PMID:20465997 formaldehyde increases expression ISO RGD:1606750 6480464 Formaldehyde results in increased expression of SLC46A1 mRNA CTD PMID:23649840 fructose multiple interactions ISO RGD:1309472 6480464 [Folic Acid affects the susceptibility to Fructose] which affects the expression of SLC46A1 mRNA CTD PMID:31612177 heme b increases uptake ISO RGD:1606750 6480464 SLC46A1 protein results in increased uptake of Heme CTD PMID:17156779 heme b multiple interactions ISO RGD:1606750 6480464 SLC46A1 protein promotes the reaction [Heme results in increased expression of HMOX1 mRNA] CTD PMID:17156779 homocysteine affects abundance EXP 6480464 SLC46A1 protein affects the abundance of Homocysteine metabolite CTD PMID:19204075 hydrogen peroxide affects expression ISO RGD:1606750 6480464 Hydrogen Peroxide affects the expression of SLC46A1 mRNA CTD PMID:20044591 ICI D1694 increases response to substance ISO RGD:1606750 6480464 SLC46A1 protein results in increased susceptibility to raltitrexed CTD PMID:21879757 L-ethionine affects expression ISO RGD:1309472 6480464 Ethionine affects the expression of SLC46A1 mRNA CTD PMID:19483382 lipopolysaccharide multiple interactions EXP 6480464 Cholecalciferol inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC46A1 mRNA] CTD PMID:25673501 lipopolysaccharide multiple interactions ISO RGD:1606750 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide decreases expression ISO RGD:1606750 6480464 Lipopolysaccharides results in decreased expression of SLC46A1 mRNA CTD PMID:35811015 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of SLC46A1 mRNA CTD PMID:25673501 methidathion increases expression EXP 6480464 methidathion results in increased expression of SLC46A1 mRNA CTD PMID:34813904 methotrexate increases response to substance ISO RGD:1606750 6480464 SLC46A1 gene SNP results in increased susceptibility to Methotrexate, SLC46A1 protein results in increased susceptibility to Methotrexate CTD PMID:21879757 , PMID:25124723 methotrexate decreases expression ISO RGD:1606750 6480464 Methotrexate results in decreased expression of SLC46A1 mRNA CTD PMID:24449571 methotrexate increases uptake ISO RGD:1606750 6480464 SLC46A1 protein results in increased uptake of Methotrexate CTD PMID:21879757 methotrexate increases transport ISO RGD:1309472 6480464 SLC46A1 protein results in increased transport of Methotrexate CTD PMID:18174275 methotrexate increases transport ISO RGD:1606750 6480464 SLC46A1 protein results in increased transport of Methotrexate CTD PMID:17475902 , PMID:19762432 methotrexate decreases activity ISO RGD:1606750 6480464 Methotrexate results in decreased activity of SLC46A1 protein CTD PMID:17475902 methotrexate multiple interactions ISO RGD:1606750 6480464 Methotrexate inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid] more ... CTD PMID:17475902 , PMID:21879757 methyl methanesulfonate increases expression ISO RGD:1606750 6480464 Methyl Methanesulfonate results in increased expression of SLC46A1 mRNA CTD PMID:23649840 miconazole increases expression EXP 6480464 Miconazole results in increased expression of SLC46A1 mRNA CTD PMID:27462272 N-nitrosodiethylamine multiple interactions ISO RGD:1309472 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SLC46A1 mRNA CTD PMID:28943392 N-nitrosodimethylamine decreases expression ISO RGD:1309472 6480464 Dimethylnitrosamine results in decreased expression of SLC46A1 mRNA CTD PMID:25380136 nefazodone decreases expression ISO RGD:1309472 6480464 nefazodone results in decreased expression of SLC46A1 mRNA CTD PMID:24136188 nitrofen decreases expression ISO RGD:1309472 6480464 nitrofen results in decreased expression of SLC46A1 mRNA CTD PMID:33484710 omeprazole affects expression ISO RGD:1309472 6480464 Omeprazole affects the expression of SLC46A1 mRNA CTD PMID:19483382 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SLC46A1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1309472 6480464 Acetaminophen results in increased expression of SLC46A1 mRNA CTD PMID:33387578 pemetrexed multiple interactions ISO RGD:1606750 6480464 Pemetrexed inhibits the reaction [SLC46A1 protein results in increased uptake of Methotrexate] CTD PMID:21879757 pemetrexed increases activity ISO RGD:1606750 6480464 Pemetrexed results in increased activity of SLC46A1 protein CTD PMID:21879757 pemetrexed increases response to substance ISO RGD:1606750 6480464 SLC46A1 protein results in increased susceptibility to Pemetrexed CTD PMID:21879757 phenylmercury acetate increases expression ISO RGD:1606750 6480464 Phenylmercuric Acetate results in increased expression of SLC46A1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1606750 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A1 mRNA CTD PMID:27188386 pirinixic acid affects expression ISO RGD:1309472 6480464 pirinixic acid affects the expression of SLC46A1 mRNA CTD PMID:19483382 potassium chromate increases expression ISO RGD:1606750 6480464 potassium chromate(VI) results in increased expression of SLC46A1 mRNA CTD PMID:22714537 pyrimethamine decreases activity ISO RGD:1606750 6480464 Pyrimethamine results in decreased activity of SLC46A1 protein CTD PMID:19762432 rotenone decreases expression ISO RGD:1309472 6480464 Rotenone results in decreased expression of SLC46A1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1606750 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1606750 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1606750 6480464 sodium arsenite results in decreased expression of SLC46A1 mRNA CTD PMID:28595984 sodium arsenite increases expression ISO RGD:1606750 6480464 sodium arsenite results in increased expression of SLC46A1 mRNA CTD PMID:22714537 sodium dichromate decreases expression ISO RGD:1309472 6480464 sodium bichromate results in decreased expression of SLC46A1 mRNA CTD PMID:25993096 Soman decreases expression ISO RGD:1309472 6480464 Soman results in decreased expression of SLC46A1 mRNA CTD PMID:19281266 sulfasalazine multiple interactions ISO RGD:1606750 6480464 Sulfasalazine inhibits the reaction [SLC46A1 protein results in increased transport of Methotrexate] CTD PMID:17475902 sulfasalazine decreases activity ISO RGD:1606750 6480464 Sulfasalazine results in decreased activity of SLC46A1 protein CTD PMID:17475902 , PMID:19762432 sulfasalazine multiple interactions ISO RGD:1309472 6480464 Sulfasalazine inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid] CTD PMID:18174275 sunitinib decreases expression ISO RGD:1606750 6480464 Sunitinib results in decreased expression of SLC46A1 mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO RGD:1606750 6480464 tert-Butylhydroperoxide results in decreased expression of SLC46A1 mRNA CTD PMID:22956110 testosterone multiple interactions ISO RGD:1309472 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of SLC46A1 mRNA CTD PMID:26496021 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC46A1 mRNA CTD PMID:17484886 thioacetamide affects expression ISO RGD:1309472 6480464 Thioacetamide affects the expression of SLC46A1 mRNA CTD PMID:19483382 thioacetamide multiple interactions ISO RGD:1309472 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SLC46A1 mRNA CTD PMID:28943392 thioacetamide decreases expression ISO RGD:1309472 6480464 Thioacetamide results in decreased expression of SLC46A1 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC46A1 mRNA CTD PMID:29950665 triptonide increases expression EXP 6480464 triptonide results in increased expression of SLC46A1 mRNA CTD PMID:33045310 trovafloxacin increases expression ISO RGD:1309472 6480464 trovafloxacin results in increased expression of SLC46A1 mRNA CTD PMID:24136188 tunicamycin increases expression ISO RGD:1606750 6480464 Tunicamycin results in increased expression of SLC46A1 mRNA CTD PMID:29453283 urethane decreases expression ISO RGD:1606750 6480464 Urethane results in decreased expression of SLC46A1 mRNA CTD PMID:28818685 valdecoxib decreases expression ISO RGD:1309472 6480464 valdecoxib results in decreased expression of SLC46A1 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:1606750 6480464 Valproic Acid results in decreased methylation of SLC46A1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1606750 6480464 Valproic Acid results in increased expression of SLC46A1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1606750 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A1 mRNA CTD PMID:27188386
